🔬Deep Research
ANNX — Annexon Inc · catalysts, narrative & risks
Annexon Inc. (ANNX) — Catalyst, Narrative, Risk, and Calendar Review
As of 2026-10-04. Not investment advice.
Recent catalysts (roughly July–October 2026)
Annexon's activity has been dominated by its two late-stage programs in Guillain-Barre Syndrome (GBS) and geographic atrophy (GA):
AI-assisted research from the K3vl4r desk — not personalized investment advice. More research →